top of page
Yong Huang, PhD
Partner, Botanical Drug Impact Fund
Dr. Huang, a distinguished figure in the realm of biomedical innovation, has navigated an illustrious career marked by academic excellence, entrepreneurial ventures, and groundbreaking contributions to the field. With a Ph.D. earned in China, Dr. Huang embarked on a journey of knowledge acquisition and application that spans continents.

After completing postdoctoral fellowships at esteemed institutions such as the University of Texas Health Science Center and Yale University, Dr. Huang showcased his academic prowess and honed his skills in the dynamic landscape of biomedical research.

In 2001, Dr. Huang co-founded the visionary "Huali Venture Capital Fund," a venture that transcended borders, covering 16 countries and regions. This endeavor reflected not only his entrepreneurial spirit but also his commitment to fostering innovation on a global scale.

Stepping onto the international stage, Dr. Huang assumed the role of Deputy Director at the "Shanghai Fenglin Life Science Park" in 2004. In this influential position, he played a key role in attracting international medical companies to Shanghai, contributing to the city's emergence as a hub for cutting-edge life sciences.

In 2006, Dr. Huang founded iSpring, where he took charge of the strategic investment division at HNA. His leadership proved instrumental in overseeing more than 10 marketplace mergers and acquisitions (M&A) deals, solidifying his reputation as a strategic thinker and a driver of financial innovation.

Demonstrating a remarkable foresight into the evolving landscape of healthcare, Dr. Huang, in 2015, established Yaoyun Capital. This venture capital firm has become a focal point for herbal medicine acquisitions and new drug development. Dr. Huang's commitment to advancing traditional herbal medicine alongside innovative drug development speaks to his deep understanding of the convergence of tradition and modernity in the medical field.

Dr. Huang's journey is a testament to his unwavering commitment to advancing biomedical ventures, from pioneering international investments to strategic leadership in influential organizations. His role in shaping the trajectory of herbal medicine acquisitions and new drug development positions him as a visionary leader, dedicated to pushing the boundaries of innovation in the dynamic and ever-evolving landscape of biomedical sciences.
bottom of page